Sustained release of VRC07 from capsule-intravaginal ring for preventing HIV transmission

Where this opportunity stands

Every notice posted under solicitation PHS-2025-1 in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Note the winner and the end of the period of performance for the recompete.
• Follow the agency to see the next notice for this work.

Who won similar work

3 award notices on SAM.gov in the last 24 months. Matched by: Same office (NATIONAL INSTITUTES OF HEALTH NIAID), same product/service code (PSC) AN11 and NAICS 541715.

Single-winner award sizes (3): middle half $600K to $1.6M, median $600K; range $599K to $2.7M.

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

• Jul 31, 2025L2 DIAGNOSTICS LLC$599KTherapeutic vaccine platform to boost immune responses in Tuberculosis
• Jul 31, 2025LYNNTECH INC.$600KB-SMART - Broadly neutralizing antibodies for SaRNA Mediated Antiviral Response Therapy
• Jul 31, 2025HBVTECH, L.L.C Germantown MD 20874 USA$2.7MEvaluating HBVZ10-Based Therapied for cccDNA Clearance: Virological Foundation and Synergistic Combinations

Competitive landscape

For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.